Neoadjuvant Modified (m) FOLFIRINOX for Locally Advanced Unresectable (LAPC) and Borderline Resectable (BRPC) Adenocarcinoma of the Pancreas-Reference-Cited by-同舟云学术

Neoadjuvant Modified (m) FOLFIRINOX for Locally Advanced Unresectable (LAPC) and Borderline Resectable (BRPC) Adenocarcinoma of the Pancreas

Published:2014-10-31 Issue:4 Volume:22 Page:1153-1159
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Blazer Marlo,Wu Christina,Goldberg Richard M.,Phillips Gary,Schmidt Carl,Muscarella Peter,Wuthrick Evan,Williams Terrence M.,Reardon Joshua,Christopher Ellison E.,Bloomston Mark,Bekaii-Saab Tanios

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-014-4225-1.pdf

Reference17 articles.

1. Seigel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2012;62:10–29.

2. Poplin E, Feng Y, Berlin J, Rothenber ML, et al. Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-min infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2009;27:3778–85.

3. Ko AH, Quivey JM, Venook AP, Bergsland EK, Dito E, Schillinger B, Tempero MA. A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2007;68:809–16.

4. Mukherjee S, Hurt C, Griffith G, et al. SCALOP: Results of a randomized phase II study of induction chemotherapy followed by gemcitabine (G) or capecitabine (Cap) based chemoradiation (CRT) in locally advanced pancreatic cancer (LANPC). J Clin Oncol. 2012;30(Suppl 34). Abstract LBA146.

5. Smeenk HG, Incrocci L, Kazemier G, et al. Adjuvant 5-FU-based chemoradiotheray for patients undergoing R1/R2 resections for pancreatic cancer. Dig Surg. 2005;22:321–8.

Cited by 220 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer;2024-07-29

2. Clinical outcomes of second-line therapy following disease progression on first-line modified FOLFIRINOX for borderline resectable and locally advanced pancreatic adenocarcinoma;Pancreatology;2024-05

3. The Oncological Stress Test of Neoadjuvant Therapy: A Systematic Review in Outcomes of Neoadjuvant Therapy Compared to Upfront Resection Approach for Borderline Resectable Pancreatic Adenocarcinoma;The American Surgeon™;2024-04-18

4. Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia;BMC Cancer;2024-04-04

5. Clinical immunotherapy in pancreatic cancer;Cancer Immunology, Immunotherapy;2024-03-02